Compound ID | 551
PD 135661
Class: Fluoroquinolone
| Spectrum of activity: | Antimycobacterial |
| Mechanism of action: | Unknown |
| Target Pathogen: | Active against Mycobacterium tuberculosis, Mycobacterium fortuitum, and Mycobacterium smegmatis |
| Description: | Renau TE, Gage JW, Dever JA, et al. Antituberculosis activity and side effect profiles of 8 new quinolones optimised for antimycobacterial effects. 36th-Intersci-Conf-Antimicrobial-Agents-Chemother 1996; 136. |
| Institute where first reported: | Parke Davis Pharmaceutical Research (Pfizer, USA) |
| Year first mentioned: | 1996 |
| Development status: | Experimental |
| External links: | |
| Citation: | https://journals.asm.org/doi/10.1128/aac.40.10.2363 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.